Fundz

Nanopath Secures $10 Million In Series A Funding To Develop And Commercialize Point-Of-Care Diagnostics For Women's Health

PRIVATEAug 09, 2022

Amount Raised

$10 Million

Round Type

Series A

CambridgeBiotechnologyHealth Care

Description

Nanopath Inc., a molecular diagnostics company enabling high-quality molecular testing in minutes, announced today that it has closed $10 million in Series A funding, co-led by Norwest Venture Partners and the Medtech Convergence Fund, a SV Health Investors venture fund, with participation from Gingerbread Capital and Green D Ventures. The funding will support development and commercialization of Nanopath's biosensing platform that aims to transform how women's pelvic and gynecologic infections are diagnosed.

Quick answer

Nanopath raised $10 Million in a Series A round, dated August 9, 2022. Nanopath is based in Cambridge, Massachusetts, United States.

How much did Nanopath raise?
Nanopath raised $10 Million in a Series A round on August 9, 2022.
What does Nanopath do?
Nanopath is a molecular diagnostics company disrupting traditional testing methodologies.
Where is Nanopath based and how big is it?
Nanopath is based in Cambridge, Massachusetts, United States. Fundz records about 25 employees.
Who are the decision-makers at Nanopath?
Fundz holds 2 contacts at Nanopath, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Nanopath, and when

A new round usually means Nanopath is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nanopath raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nanopath, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nanopath. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nanopath

Location

Cambridge, Massachusetts, United States

About

Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nanopath raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAmogha T., Co-Founder & CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nanopath's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Nanopath raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.